<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Babiker Bashir Haroun Baraka</style></author><author><style face="normal" font="default" size="100%">Bhagya Venkanna Rao</style></author><author><style face="normal" font="default" size="100%">Tanuja Krishnamurthy</style></author><author><style face="normal" font="default" size="100%">Ramya Vasudev</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Housing In An Enriched Environment Enhances The Neuroprotective Effect Of Celastrus Paniculatus And Tribulus Terrestris In An Animal Model Of Chronic Stress</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Chronic Immobilization stress</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Enriched Environment</style></keyword><keyword><style  face="normal" font="default" size="100%">Hippocampus</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurotrophic factor</style></keyword><keyword><style  face="normal" font="default" size="100%">Pro-inflammatory cytokines</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">191-202</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Prolonged exposure to stress can contribute to depressive episodes. Preclinical studies have shown that stimuli like environmental enrichment (EE) can produce beneficial effects against stress by positively modulating neuroplasticity, neurochemistry, and behaviour. Hence, we explored whether exposure to EE can augment the neuroprotective activities of &lt;em&gt;Celastrus paniculatus&lt;/em&gt; (CP) and &lt;em&gt;Tribulus terrestris&lt;/em&gt; (TT) in stressed conditions. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; Rats were placed in immobilisation bags and stressed for two hours a day for ten days. After that, these stressed rats were treated by CP or TT, alone or in combination with enriched housing. Behavioural analysis in elevated plus maze, open field, forced swim and sucrose preference tests. The novel object recognition test and the rewarded alteration test on the T-maze were used to assess working memory. The brain-derived neurotrophic factor, interleukin-6, and tumour necrotic factor-alpha were measured in the hippocampus and prefrontal cortical tissues following stress and herbal treatment combined with an enriched environment.&lt;strong&gt; Results: &lt;/strong&gt;We found that &lt;em&gt;Celastrus paniculatus&lt;/em&gt; and &lt;em&gt;Tribulus terrestris&lt;/em&gt;, combined with an enriched environment, produced a synergistic neuroprotective effect. CP + EE and TT + EE improved working memory and recognition memory in CIS animals, but they also reduced anxiety and depressive-like behaviours. TNF-α and IL-6 levels were decreased while brain-derived neurotrophic factor levels were raised in the frontal cortex and hippocampus regions, respectively.&lt;strong&gt; Conclusion: &lt;/strong&gt;Our results show that living in an enriched environment can improve CP and TT neuromodulatory activities, highlighting the potential of combining sensory-motor interventions with herbal remedies for psychiatric disorders.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">191</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Babiker Bashir Haroun Baraka&lt;sup&gt;1,2&lt;/sup&gt;, Bhagya Venkanna Rao&lt;sup&gt;1*&lt;/sup&gt;, Tanuja Krishnamurthy&lt;sup&gt;1&lt;/sup&gt;, Ramya Vasudev&lt;sup&gt;1&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, KLE College of Pharmacy, KLE Academy of Higher Education and Research Rajajinagar, Bengaluru-560010, Karnataka, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Dr.Prabhakar B Kore Basic Science Research Centre, KLE College of Pharmacy, KLE Academy of Higher Education and Research Rajajinagar, Bengaluru-560010, Karnataka, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Christina Peter</style></author><author><style face="normal" font="default" size="100%">Halimat Yusuf Lukman</style></author><author><style face="normal" font="default" size="100%">Nosipho Wendy S’thebe</style></author><author><style face="normal" font="default" size="100%">Usman Abiola Sanni</style></author><author><style face="normal" font="default" size="100%">Saheed SABIU</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Mechanistic Insights on the Neuro-Modulatory Potential of Cannabis sativa: A Network Pharmacology- and Molecular Dynamics Simulation-Based Approach</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Cannabinoid receptors</style></keyword><keyword><style  face="normal" font="default" size="100%">Cannabis</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurological diseases</style></keyword><keyword><style  face="normal" font="default" size="100%">Neurotransmitters</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">407-419</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Although, studies have reported the use of cannabis as a temporary antidepressant and implicated its chronic use in neurological diseases, the exact mechanisms through which these happen remain elusive. &lt;strong&gt;Objective:&lt;/strong&gt; This study aims to investigate the neuro-modulatory potential of cannabis as antidepressant and its role in neurological disorders &lt;strong&gt;Methodology: &lt;/strong&gt;Network pharmacology and molecular dynamics simulation were employed to unveil the mechanism of cannabis as a temporary antidepressant and potential agent implicated in neurological disorders.&lt;strong&gt; Results: &lt;/strong&gt;A total of 156 cannabis metabolites were retrieved from data mining. 22 genes were common in cannabis metabolites and central nervous system (&lt;em&gt;CNS&lt;/em&gt;) neurotransmitters’ genes. Glutamate receptor activity and neuroactive ligand receptor activity (&lt;em&gt;NALR&lt;/em&gt;) were the most enriched biological process and signalling pathway, respectively, with cannabinoid receptor 1 (&lt;em&gt;CNR1)&lt;/em&gt; and glutamate metabotropic receptor 2 (&lt;em&gt;GRM2&lt;/em&gt;) being the hub targets in the NALR pathway. A probe into the structural stability of top-ranked metabolites identified cholesterol- &lt;em&gt;CNR1&lt;/em&gt; (-73.88 kcal/mol) and campesterol-&lt;em&gt;CNR1&lt;/em&gt; (-65.96 kcal/mol) with lower free binding energy than reference antidepressant drug (anandamide) (-65.08 kcal/mol), whereas for &lt;em&gt;GRM2&lt;/em&gt;, the binding free energy of nerolidol (-43.57 kcal/mol) which was the least among the top ranked metabolites was higher compared to anandamide (-58.78 kcal/mol). &lt;strong&gt;Conclusion: &lt;/strong&gt;Data from this study shows that the profiled cannabis metabolites displayed modulatory effects on key neurotransmitters of the CNS and their receptors and formed stable binding interaction with genes implicated in brain functioning suggestive of the mechanistic effect of cannabis on brain activity during depression and chronic use.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">407</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Christina Peter&lt;sup&gt;1&lt;/sup&gt;, Halimat Yusuf Lukman&lt;sup&gt;1&lt;/sup&gt;, Nosipho Wendy S’thebe&lt;sup&gt;1&lt;/sup&gt;, Usman Abiola Sanni&lt;sup&gt;2,3&lt;/sup&gt;, Saheed Sabiu&lt;sup&gt;1*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, P. O. Box 1334, Durban 4000, SOUTH AFRICA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Paediatrics, Federal Medical Centre, Birnin Kebbi, Nigeria, WEST AFRICA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Partners in Health, Koidu, Kono, Sierra Leone, WEST AFRICA&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paul Alan Arkin Alvarado-García</style></author><author><style face="normal" font="default" size="100%">Marilú Roxana Soto-Vásquez</style></author><author><style face="normal" font="default" size="100%">Luis Enrique Rosales-Cerquin</style></author><author><style face="normal" font="default" size="100%">Santiago M. Benites</style></author><author><style face="normal" font="default" size="100%">Taniht Lisseth Cubas-Romero</style></author><author><style face="normal" font="default" size="100%">Demetrio Rafael Jara-Aguilar</style></author><author><style face="normal" font="default" size="100%">José Gilberto Gavidia-Valencia</style></author><author><style face="normal" font="default" size="100%">Iris Melina Alfaro-Beltrán</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Rosmarinus Officinalis Essential Oil On Anxiety, Depression, And Sleep Quality</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anxiety</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Essential oils</style></keyword><keyword><style  face="normal" font="default" size="100%">Rosmarinus officinalis</style></keyword><keyword><style  face="normal" font="default" size="100%">Sleep quality</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">343-349</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The objective of this investigation was to evaluate the effect of &lt;em&gt;Rosmarinus officinalis &lt;/em&gt;essential oil on anxiety, depression, and sleep quality. &lt;strong&gt;Methods: &lt;/strong&gt;The essential oils were extracted by hydro-distillation using a modified Clevenger-type apparatus and the chemical composition was performed by Gas chromatography with flame ionization detection (GC-FID) and Gas chromatography mass spectrometry (GC–MS). Furthermore, a quasi-experimental study was conducted, where 81 participants were divided into two groups, comprising a waiting list control group and an experimental group treated with essential oils. Anxiety and depression indexes were evaluated using the Zung Self-Rating Anxiety Scale (SAS) and the Zung Self-Rating Depression Scale (SDS), and sleep quality was measured with the Pittsburgh Sleep Quality Inventory (PSQI). &lt;strong&gt;Results:&lt;/strong&gt; Chemical analysis showed that 1,8 cineole (37.6%), α-pinene (19.9%), and linalool (15.8%) were the main components. Anxiety, depression, and sleep quality scores showed a decrease in the post-test study phase compared to the pre-test in the experimental group (p&amp;lt;0.05). A large size effect was found in the case of anxiety (d = 1.491; g= 1.490) with 1-β=0.996, while medium size effects were observed for depression (d = 0.581; g= 0.582) with 1-β=0.585; and sleep quality (d = 0.586; g = 0.588) with 1-β=0.638. &lt;strong&gt;Conclusion: &lt;/strong&gt;Essential oils extracted from &lt;em&gt;Rosmarinus officinalis&lt;/em&gt; are more effective in calming anxiety and show moderate changes in depression and sleep quality.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">343</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Paul Alan Arkin Alvarado-García&lt;sup&gt;1,*&lt;/sup&gt;, Marilú Roxana Soto-Vásquez&lt;sup&gt;2&lt;/sup&gt;, Luis Enrique Rosales-Cerquin&lt;sup&gt;3&lt;/sup&gt;, Santiago M. Benites&lt;sup&gt;4&lt;/sup&gt;, Taniht Lisseth Cubas- Romero&lt;sup&gt;1&lt;/sup&gt;, Demetrio Rafael Jara- Aguilar&lt;sup&gt;2&lt;/sup&gt;, José Gilberto Gavidia-Valencia&lt;sup&gt;2&lt;/sup&gt;, Iris Melina Alfaro-Beltrán&lt;sup&gt;5&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Escuela de Psicología. Universidad Autónoma del Perú. Lima, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Facultad de Farmacia y Bioquímica. Universidad Nacional de Trujillo, Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Hospital de Apoyo Chepén, Chepén, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Universidad Autónoma del Perú. Lima, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Instituto Pablo Casals, Trujillo, PERÚ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ns. Grace C Sipasulta</style></author><author><style face="normal" font="default" size="100%">Indah Nur Imamah</style></author><author><style face="normal" font="default" size="100%">Genevieva E Tanihatu</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Experiences and Expectations of Post-Partum Mothers Toward Psychosocial Nursing Services for Mothers Who Have Experienced Postpartum Blues in City of Balikpapan</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Baby Blues</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Postpartum</style></keyword><keyword><style  face="normal" font="default" size="100%">Psychosocial Services.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">471-478</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;After giving birth, the mother feels happy to finally be able to meet her beloved baby. However, some mothers actually do not feel happy but appear feelings of sadness, anxiety, and depression after giving birth. As many as 30-75 present of women can experience baby blues after giving birth and one in seven women can experience postpartum depression. Health Education needs to be improved and Nutrition for pregnant women needs attention Micronutrients prevent postpartum depression so that babies are born healthy. Based on the above problems that are still untouched by promotion and prevention health for women overcome the level of emotional anxiety from pregnancy to post-delivery which can be experienced by mothers from mild, moderate to severe. Nurses play a key role related to providing physical and psychological care to support the improvement of the mother's condition towards more positive. Mothers are at risk for natural emotional problems requiring someone to be able to give him an understanding of the process he is going through and help him to remain in a more stable condition. This study involved seven participants with diverse characteristics and provided an overview and the high need of postpartum mothers to feel comfortable so that their coping efforts could be achieved so that they did not experience emotional problems after giving birth.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Review Article</style></work-type><section><style face="normal" font="default" size="100%">471</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Ns. Grace C Sipasulta&lt;sup&gt;1&lt;/sup&gt;, Indah Nur Imamah&lt;sup&gt;1*&lt;/sup&gt;, Genevieva E Tanihatu&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;East Kalimantan Health Polytechnic D-III Nursing Program Balikpapan, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Univercity of Persada Indonesia Y.A.I, Jakarta, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paul Alan Arkin Alvarado-García</style></author><author><style face="normal" font="default" size="100%">Marilú Roxana Soto-Vásquez</style></author><author><style face="normal" font="default" size="100%">Luis Enrique Rosales-Cerquin</style></author><author><style face="normal" font="default" size="100%">Elda Maritza Rodrigo-Villanueva</style></author><author><style face="normal" font="default" size="100%">Demetrio Rafael Jara-Aguilar</style></author><author><style face="normal" font="default" size="100%">Lurdes Tuesta-Collantes</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anxiolytic and Antidepressant-like Effects of Foeniculum vulgare Essential Oil</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anxiety</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Essential oils</style></keyword><keyword><style  face="normal" font="default" size="100%">Foeniculum vulgare</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">425-431</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: The aim of this research was to determine the anxiolytic and antidepressant-like effects of the essential oils from &lt;em&gt;Foeniculum vulgare &lt;/em&gt;aerial parts and seeds.&lt;strong&gt; Methods&lt;/strong&gt;: The oils were extracted by hydro-distillation using a modified Clevenger-type apparatus and chemical composition was performed by Gas chromatography with flame-ionization detection (GC-FID) and Gas chromatography-mass spectrometry (GC–MS). Furthermore, an experimental trial was conducted, where 117 participants were divided into three groups, comprising a waiting list control group and two experimental groups treated with essential oils. The anxiety and depression indexes were evaluated by Zung Self-Rating Anxiety Scale (SAS) and Zung Self-Rating Depression Scale (SDS). &lt;strong&gt;Results: &lt;/strong&gt;chemical analysis showed that trans- Anethole was the main component, both in the essential oil from aerial parts (35.5%) and seeds (79.2%). Anxiety and depression scores showed a decrease in posttest study phase in comparison with pretest in all experimental groups (p&amp;lt;0.05), except for depression scores in the group treated with essential oil from aerial parts (p&amp;gt;0.05). Small changes were found in the case of anxiety for group treated with essential oils from aerial parts (d = 0.41; Δ= 0.40) while moderate (d = 0.86; Δ = 0.85) and small (d = 0.38; Δ = 0.39) changes were found for anxiety and depression respectively, in the group treated with essential oil from seeds. &lt;strong&gt;Conclusion:&lt;/strong&gt; The essential oil from &lt;em&gt;Foeniculum vulgare&lt;/em&gt; seeds is more effective to relief anxiety than depression while the essential oil from&lt;em&gt; Foeniculum vulgare&lt;/em&gt; aerial parts only exhibit small changes for anxiety.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article </style></work-type><section><style face="normal" font="default" size="100%">425</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Paul Alan Arkin Alvarado- García&lt;sup&gt;1,*&lt;/sup&gt;, Marilú Roxana Soto-Vasquez&lt;sup&gt;2&lt;/sup&gt;, Luis Enrique Rosales-Cerquin&lt;sup&gt;1&lt;/sup&gt;, Elda Maritza Rodrigo-Villanueva&lt;sup&gt;2&lt;/sup&gt;, Demetrio Rafael Jara-Aguilar&lt;sup&gt;2&lt;/sup&gt;, Lurdes Tuesta-Collantes&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Escuela de Medicina. Universidad César Vallejo, Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Facultad de Farmacia y Bioquímica. Universidad Nacional de Trujillo, Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Facultad de Ciencias Biológicas. Universidad Nacional de Trujillo, Trujillo, PERÚ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paul Alan Arkin Alvarado-García</style></author><author><style face="normal" font="default" size="100%">Marilú Roxana Soto-Vásquez</style></author><author><style face="normal" font="default" size="100%">Francisco Mercedes Infantes Gomez</style></author><author><style face="normal" font="default" size="100%">Yolanda Elizabeth Rodríguez de Guzmán</style></author><author><style face="normal" font="default" size="100%">Taniht Lisseth Cubas Romero</style></author><author><style face="normal" font="default" size="100%">Natalia Mavila Guzmán Rodríguez</style></author><author><style face="normal" font="default" size="100%">Olga Gessy Rodríguez Aguilar</style></author><author><style face="normal" font="default" size="100%">Ana María Honores Alvarado</style></author><author><style face="normal" font="default" size="100%">Elsa Rocío Vargas Díaz</style></author><author><style face="normal" font="default" size="100%">Lesly Alexandra Cabrera Cabrera</style></author><author><style face="normal" font="default" size="100%">Klersy Almendra Truyenque Román</style></author><author><style face="normal" font="default" size="100%">Edwar Guido Briceño Esquivel</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effects of Satureja brevicalyx essential oil inhalation on coping premenstrual syndrome</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anxiety</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Essential oils</style></keyword><keyword><style  face="normal" font="default" size="100%">Premenstrual syndrome</style></keyword><keyword><style  face="normal" font="default" size="100%">Satureja brevicalyx</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">728-735</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;The aim of this research was to evaluate the effects of&lt;em&gt; Satureja brevicalyx&lt;/em&gt; essential oil inhalation on premenstrual syndrome.&lt;strong&gt; Methods:&lt;/strong&gt; The oils were extracted by hydro-distillation using a modified Clevenger-type apparatus and chemical composition was performed by Gas chromatography-mass spectrometry (GC–MS). Furthermore, a quasi-experimental study was conducted, where 61 participants were divided in two groups, comprising an experimental with essential oils and a control group with no treatment. Main psychological symptoms were assessed with the used of Zung Self-Rating Anxiety Scale (SAS) and Zung Self-Rating Depression Scale (SDS) as well as total score of premenstrual syndrome was evaluated with Premenstrual Syndrome Scale (PMSS).&lt;strong&gt; Results:&lt;/strong&gt; chemical analysis showed that linalool (17.6%) was the main component. All variables showed a decrease in posttest study phase in comparison with pretest in experimental group (p&amp;lt;0.05). A large size effect was observed for anxiety (d = 1.25; Δ = 1.35). Besides, moderate changes were found for depression (d = 0.79; Δ= 0.81) and premenstrual syndrome total score (d = 0.62; Δ = 0.56)&lt;strong&gt;. Conclusion: &lt;/strong&gt;The essential oil of&lt;em&gt; Satureja brevicalyx &lt;/em&gt;exerts a potencial use, especially for the treatment of psychological symptoms of premenstrual syndrome.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">728</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Paul Alan Arkin Alvarado-García&lt;sup&gt;1,*&lt;/sup&gt;, Marilú Roxana Soto-Vásquez&lt;sup&gt;2&lt;/sup&gt;, Francisco Mercedes Infantes Gomez&lt;sup&gt;1&lt;/sup&gt;, Yolanda Elizabeth Rodríguez de Guzmán&lt;sup&gt;3&lt;/sup&gt;, Taniht Lisseth Cubas Romero&lt;sup&gt;4&lt;/sup&gt;, Natalia Mavila Guzmán Rodríguez&lt;sup&gt;5&lt;/sup&gt;, Olga Gessy Rodríguez Aguilar&lt;sup&gt;6&lt;/sup&gt;, Ana María Honores Alvarado&lt;sup&gt;6&lt;/sup&gt;, Elsa Rocío Vargas Díaz&lt;sup&gt;6&lt;/sup&gt;, Lesly Alexandra Cabrera Cabrera&lt;sup&gt;1&lt;/sup&gt;, Klersy Almendra Truyenque Román&lt;sup&gt;1&lt;/sup&gt;, Edwar Guido Briceño Esquivel&lt;sup&gt;1&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Escuela de Medicina. Universidad César Vallejo, Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Facultad de Farmacia y Bioquímica. Universidad Nacional de Trujillo, Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Facultad de Enfermería. Universidad Nacional de Trujillo, Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Universidad Autónoma del Perú, Lima, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Escuela de Psicología. Universidad César Vallejo, Trujillo, PERÚ.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Escuela de Enfermería. Universidad Privada Antenor Orrego, Trujillo, PERÚ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Maulana Farid Rizki</style></author><author><style face="normal" font="default" size="100%">Paulus Sugianto</style></author><author><style face="normal" font="default" size="100%">Margarita Maria Maramis</style></author><author><style face="normal" font="default" size="100%">Soetjipto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Viral Meningoencephalitis Patient with Comorbid Major Depression with Psychotic Symptoms: A Case Report</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Comorbid</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Viral meningoencephalitis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2022</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2022</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">14</style></volume><pages><style face="normal" font="default" size="100%">455-458</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Viral meningoencephalitis causes meninges and brain parenchyma inflammation, thus provoking significant morbidity and mortality. Clinical features include neurological and psychiatric symptoms depending on the brain involved, mild symptoms such as fever, headache, neck stiffness, and confusion, or severe symptoms such as seizures, weakness, hallucinations, and coma. Therefore, the clinical diagnosis and treatment of such cases are challenging to make. This case report describes an adult male patient suffering from viral meningoencephalitis with comorbid major depression with psychotic symptoms. The patient requires holistic management of meningoencephalitis with comorbid depression and neuropsychiatric symptoms that may occur in the long term.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Case Report</style></work-type><accession-num><style face="normal" font="default" size="100%">29</style></accession-num><section><style face="normal" font="default" size="100%">455</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Maulana Farid Rizki&lt;sup&gt;1&lt;/sup&gt;, Paulus Sugianto&lt;sup&gt;2,*&lt;/sup&gt;, Margarita Maria Maramis&lt;sup&gt;3&lt;/sup&gt;, Soetjipto&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Resident, Department of Neurology, Faculty of Medicine, Airlangga University, Dr. Soetomo General Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Medical Staff, Department of Neurology, Faculty of Medicine, Airlangga University, Dr. Soetomo General Hospital, Surabaya, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Medical Staff, Department of Psychiatry, Faculty of Medicine, Airlangga University, Dr. Soetomo General Hospital, Surabaya, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marcos Ignacio Jimenez Zuniga</style></author><author><style face="normal" font="default" size="100%">Alejandro Jonathan Hurtado Mariles</style></author><author><style face="normal" font="default" size="100%">Jose Luis Castrejon Flores</style></author><author><style face="normal" font="default" size="100%">Jose Antonio Mondragon Herrera</style></author><author><style face="normal" font="default" size="100%">Maria Guadalupe Ramirez Sotelo</style></author><author><style face="normal" font="default" size="100%">Genaro Ivan Ceron Montes</style></author><author><style face="normal" font="default" size="100%">Yolanda de las Mercedes Gomez y Gomez</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antidepressant-Like Effects of Dracocephalum moldavica L. in Mouse Models of Immobility Tests</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Dracochepalum moldavica L.</style></keyword><keyword><style  face="normal" font="default" size="100%">Forced swim test</style></keyword><keyword><style  face="normal" font="default" size="100%">Tail suspension test</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">September 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">976-983</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;The aim of this investigation was to evaluate the antidepressant activity of the ethanolic extracts of “toronjil azul”(&lt;em&gt;Dracocephalum moldavica&lt;/em&gt; L.). &lt;strong&gt;Methodology:&lt;/strong&gt; The forced swimming test (FST) and tail suspension test (TST) were performed on CD-1 mice to evaluate the antidepressant activity of the ethanolic extracts. The ethanolic extracts were administered orally at an 80 and 100 mg/kg. The animals were dosed 1, 6 and 24 h before initiating the FST assay and 40 minutes before for the TST assay. Imipramine and fluoxetine were dosed at 15 mg/kg, while the flavonoid quercetin was given an a lower concentration of 10 mg/kg as a positive controls. &lt;strong&gt;Results:&lt;/strong&gt; The extracts of &lt;em&gt;Dracocephalum moldavica&lt;/em&gt; L. and significantly decreased the immobility time in the FST and TST assays when compared with the negative control and reported similar values than those obtained with the positive controls. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results obtained indicate that extract of &lt;em&gt;Dracocephalum moldavica&lt;/em&gt; L. have antidepressant effect similar to those obtained by.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">976</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Marcos Ignacio Jiménez Zúñiga&lt;sup&gt;1&lt;/sup&gt;, Alejandro Jonathan Hurtado Mariles&lt;sup&gt;1&lt;/sup&gt;, José Luis Castrejón Flores&lt;sup&gt;2&lt;/sup&gt;, José Antonio Mondragón Herrera&lt;sup&gt;1,3&lt;/sup&gt;, María Guadalupe Ramírez Sotelo&lt;sup&gt;1&lt;/sup&gt;, Genaro Iván Cerón Montes&lt;sup&gt;4&lt;/sup&gt;, Yolanda de las Mercedes Gómez y Gómez&lt;sup&gt;1,&lt;/sup&gt;* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Laboratorio de Farmacología, Instituto Politécnico Nacional, Unidad Profesional Interdisciplinaria de Biotecnología, MEXICO.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Laboratorio de Biotecnología Molecular y Cultivo Celular, Av. Acueducto, La Laguna Ticomán, C.P.: 07340, Gustavo A. Madero, Ciudad de México, MEXICO.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Centro Médico Nacional Siglo XXI, Hospital de Cardiología, Laboratorio de Patología Molecular, Avenida Cuauhtémoc 330, Doctores, C.P.: 06720, Cuauhtémoc, Ciudad de MEXICO.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Universidad Tecnológica de Tecámac, Laboratorio de Bioprocesos, Carretera Federal México-Pachuca, Km. 37.5, Predio Sierra Hermosa, C.P. 55740. Tecámac, Estado de México, MEXICO.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tácuna-Calderón Ana Lucia</style></author><author><style face="normal" font="default" size="100%">Huaccho-Rojas Juan Jesus</style></author><author><style face="normal" font="default" size="100%">Zimic-Zare Carolina</style></author><author><style face="normal" font="default" size="100%">Pante-Medina Carlos</style></author><author><style face="normal" font="default" size="100%">Salazar-Granara Alberto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antidepressant and Antipsychotic-like Activity of the Ethanolic Extract of the Leaves of Maytenus macrocarpa</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Chuchuhuasi</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Fluoxetine</style></keyword><keyword><style  face="normal" font="default" size="100%">Forced swim test</style></keyword><keyword><style  face="normal" font="default" size="100%">Haloperidol</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">s33-s37</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; &lt;em&gt;Maytenus macrocarpa&lt;/em&gt; (Chuchuhuasi) is an Amazonian Peruvian traditional plant, traditionally used as anti-inflammatory, antipyretic, antihemorrhagic and antidiarrheic agent. Also, chuchuhuasi is known as a master plant, attributing to it properties in the central nervous system. In addition, depression is a disorder of the mood that cause disability to millions of people around the world. For this reason, the aim of this study was to determinate the antidepressant and antipsychotic-like activity of the ethanolic extract of Maytenus macrocarpa&lt;strong&gt;. Methods:&lt;/strong&gt; It was used the ethanolic extract of the leaves of &lt;em&gt;Maytenus macrocarpa&lt;/em&gt; (EELMM) in female mice at the experimental model of the Forced Swim Test described by Porsolt. As control, it was used distillate water, fluoxetine and haloperidol. &lt;strong&gt;Results:&lt;/strong&gt; The immobility time of the groups of EELMM has a mean of 38.26 &amp;plusmn; 21.57, 84.32 &amp;plusmn; 26.68 and 32.17 &amp;plusmn; 25.55 for the doses of 750, 1000 and 1250 mg/Kg respectively; and the immobility time had a median of 7.5 [4.07 &amp;ndash; 20.3] and 20.93 &amp;plusmn; [17.63 &amp;ndash; 23.75] for the doses of 500 mg/Kg and 1500 mg/Kg. It was seen a positive dose-response between the dose of 500 to 1000 mg/Kg (Pearson correlation of r=0.8339 and R=0.6954) and a negative dose-response between the dose of 1000 to 1500 mg/Kg. (Pearson correlation of r= -0.7590 and R= 0.5760). &lt;strong&gt;Conclusion:&lt;/strong&gt; It was demonstrated the antidepressant-like activity of the ethanolic extract of the leaves of &lt;em&gt;Maytenus macrocarpa&lt;/em&gt; with a dose of 500 mg/kg and an antipsychotic-like activity with a dose of 1000 mg/kg.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">s33</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;T&amp;aacute;cuna-Calder&amp;oacute;n Ana Lucia&lt;sup&gt;1,2,3&lt;/sup&gt;, Huaccho-Rojas Juan Jesus&lt;sup&gt;1,2,3&lt;/sup&gt;, Zimic-Zare Carolina&lt;sup&gt;1,2&lt;/sup&gt;, Pante-Medina Carlos&lt;sup&gt;1&lt;/sup&gt;, Salazar-Granara Alberto&lt;sup&gt;1,2,3*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt; 1&lt;/sup&gt;Universidad de San Martin de Porres, Facultad de Medicina Humana, Centro de Investigaci&amp;oacute;n de Medicina Tradicional y Farmacolog&amp;iacute;a, Lima, PERU.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt; 2&lt;/sup&gt;Universidad Peruana Cayetano Heredia, Facultad de Ciencias y Filosof&amp;iacute;a, Secci&amp;oacute;n Bioqu&amp;iacute;mica, Biolog&amp;iacute;a molecular y Farmacolog&amp;iacute;a, Lima, PERU.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt; 3&lt;/sup&gt;Sociedad Peruana de Farmacologia y Terap&amp;eacute;utica Experimental (SOPFARTEX), Lima, PERU.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lalit Sharma</style></author><author><style face="normal" font="default" size="100%">Aditi Sharma</style></author><author><style face="normal" font="default" size="100%">Girdhari Lal Gupta</style></author><author><style face="normal" font="default" size="100%">Gopal Singh Bisht</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Pharmacological Evaluation of Bacopa monnieri Extract against Depressive like Behavior Induced by Ethanol Withdrawal in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Bacopa monnieri</style></keyword><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Ethanol withdrawal syndrome</style></keyword><keyword><style  face="normal" font="default" size="100%">Histopathology</style></keyword><keyword><style  face="normal" font="default" size="100%">Locomotor hyperactivity</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2018</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">s48-s53</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Alcohol withdrawal syndrome lead to relapse to alcohol use and depression is the most common symptom of withdrawal. &lt;em&gt;Bacopa&lt;/em&gt; &lt;em&gt;monnieri&lt;/em&gt; is a traditional memory enhancer and has reported antidepressant properties as well. &lt;strong&gt;Objective:&lt;/strong&gt; The present study was designed to evaluate the protective effects of &lt;em&gt;Bacopa monnieri&lt;/em&gt; extract in alcohol withdrawal depressive-like behavior in alcohol-dependent rats. &lt;strong&gt;Methods:&lt;/strong&gt; Plant drug was extracted with ethanol (70% v/v) using soxhlet extraction. Ethanol 7.2%, v/v was given to the rats in a liquid diet for 21 days and then was withdrawn from the diet and animals were observed at 6&lt;sup&gt;th&lt;/sup&gt; and 24th h for withdrawal signs like depressive behavior and locomotor hyperactivity. &lt;strong&gt;Results:&lt;/strong&gt; The phytochemical testing of extract revealed the presence of flavonoids, alkaloids, steroids, and tannins.&lt;em&gt; Bacopa monnieri&lt;/em&gt; extract (100, 200 and 300 mg/kg, oral) and fluoxetine (10 mg/kg i.p) treatment at the 6&lt;sup&gt;th&lt;/sup&gt; and 24&lt;sup&gt;th&lt;/sup&gt; h of ethanol withdrawal produced the significant (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.001) decrease in the immobility time as compared to the disease control rats when tested on forced swim test and tail suspension test. &lt;em&gt;Bacopa monnieri&lt;/em&gt; extract and fluoxetine treatment produced significant (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.001) inhibitory effects on locomotor hyperactivity as well. Histopathological examination did not show any remarkable pathological and microscopic changes. &lt;strong&gt;Conclusion:&lt;/strong&gt; Findings from the present study showed that&lt;em&gt; Bacopa monnieri&lt;/em&gt; extract treatment has beneficial effects on ethanol withdrawal depressive-like behavior in rats.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">s48</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Lalit Sharma&lt;sup&gt;1&lt;/sup&gt;, Aditi Sharma&lt;sup&gt;2&lt;/sup&gt;, Girdhari Lal Gupta&lt;sup&gt;3,*&lt;/sup&gt;, Gopal Singh Bisht&lt;sup&gt;4,* &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacy, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;School of Pharmaceutical Sciences, Shoolini University, Solan, Himachal Pradesh, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmacology, SPPSPTM, SVKM&amp;rsquo;S NMIMS University, Mumbai, Maharashtra- 400 056, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of BT and BI, Jaypee University of Information Technology, Waknaghat, Solan, Himachal Pradesh, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rajeshwari Shastry</style></author><author><style face="normal" font="default" size="100%">Aadhya Sharma</style></author><author><style face="normal" font="default" size="100%">Vinay Sayeli</style></author><author><style face="normal" font="default" size="100%">Ullal Sheetal Dinkar</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Screening of Antidepressant Activity of Punica granatum in Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Depression</style></keyword><keyword><style  face="normal" font="default" size="100%">Forced swim test</style></keyword><keyword><style  face="normal" font="default" size="100%">Pomegranate.</style></keyword><keyword><style  face="normal" font="default" size="100%">Tail suspension test</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">27-29</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; India is a rich source of medicinal plants used therapeutically to treat various disorders including depression. This study was undertaken to evaluate the antidepressant effect of acute and chronic administration of &lt;em&gt;Punica granatum&lt;/em&gt; (pomegranate) whole fruit in mice. &lt;strong&gt;Methods:&lt;/strong&gt; We used the aqueous extract of &lt;em&gt;Punica granatum &lt;/em&gt;(250 and 500 mg/kg per day), standard drug used was Imipramine (10 mg/kg) and vehicle was gum acacia (10 ml/kg), orally. Four groups of animals were used and each group had six animals. In the acute study drugs/vehicles were administered 60 min prior to the experiments. In the chronic study drugs/vehicles were administered for 14 days and the last dose was given on the 14&lt;sup&gt;th&lt;/sup&gt; day, 60 minutes prior to experiment. Forced Swim Test and Tail Suspension Test were used for testing antidepressant activity. Data was analyzed using one-way ANOVA with drug treatment as the independent factor. Post-hoc comparisons were performed using Dunnett&amp;rsquo;s test. &lt;strong&gt;Results: &lt;/strong&gt;In acute and chronic forced swim test as well as acute tail suspension test, duration of immobility was significantly reduced in the PG 500 mg/kg, but not in the 250 mg/kg treated group. In chronic tail suspension test, duration of immobility was significantly decreased in PG 250 mg/kg and 500 mg/kg treated groups. The antidepressant activity of 500 mg/kg was comparable to that of Imipramine 10 mg/kg. &lt;strong&gt;Conclusion:&lt;/strong&gt; The present study suggests that aqueous extract of whole fruit of P. granatum has antidepressant activity at 500 mg/kg. It would be advisable to encourage consumption of pomegranate extract in patients with depression because of its nutritional and functional properties.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">27</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Rajeshwari Shastry, Aadhya Sharma, Vinay Sayeli, Ullal Sheetal Dinkar* &lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;Department of Pharmacology, Kasturba Medical College, Mangaluru,Manipal University, Karnataka, INDIA.&lt;/p&gt;
</style></auth-address></record></records></xml>